FR2415639A1 - Antigene de surface de l'hepatite b - Google Patents

Antigene de surface de l'hepatite b

Info

Publication number
FR2415639A1
FR2415639A1 FR7802322A FR7802322A FR2415639A1 FR 2415639 A1 FR2415639 A1 FR 2415639A1 FR 7802322 A FR7802322 A FR 7802322A FR 7802322 A FR7802322 A FR 7802322A FR 2415639 A1 FR2415639 A1 FR 2415639A1
Authority
FR
France
Prior art keywords
banding
hepatitis
ammonium sulphate
surface antigen
isopycnic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7802322A
Other languages
English (en)
French (fr)
Other versions
FR2415639B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to FR7802322A priority Critical patent/FR2415639A1/fr
Publication of FR2415639A1 publication Critical patent/FR2415639A1/fr
Application granted granted Critical
Publication of FR2415639B1 publication Critical patent/FR2415639B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR7802322A 1978-01-27 1978-01-27 Antigene de surface de l'hepatite b Granted FR2415639A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7802322A FR2415639A1 (fr) 1978-01-27 1978-01-27 Antigene de surface de l'hepatite b

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7802322A FR2415639A1 (fr) 1978-01-27 1978-01-27 Antigene de surface de l'hepatite b

Publications (2)

Publication Number Publication Date
FR2415639A1 true FR2415639A1 (fr) 1979-08-24
FR2415639B1 FR2415639B1 (enExample) 1980-07-18

Family

ID=9203900

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7802322A Granted FR2415639A1 (fr) 1978-01-27 1978-01-27 Antigene de surface de l'hepatite b

Country Status (1)

Country Link
FR (1) FR2415639A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470795A1 (fr) * 1979-12-07 1981-06-12 Pasteur Institut Procede de purification de particules d'origine biologique, notamment de l'antigene de surface du virus de l'hepatite b (aghbs) et les produits obtenus

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470795A1 (fr) * 1979-12-07 1981-06-12 Pasteur Institut Procede de purification de particules d'origine biologique, notamment de l'antigene de surface du virus de l'hepatite b (aghbs) et les produits obtenus

Also Published As

Publication number Publication date
FR2415639B1 (enExample) 1980-07-18

Similar Documents

Publication Publication Date Title
US4581010A (en) Method of immonosuppression after transplantation of cells, tissues and organs
Berenson et al. Positive selection of viable cell populations using avidin-biotin immunoadsorption
Klein et al. EBV‐associated serological patterns in a Burkitt lymphoma patient during regression and recurrence
Ross et al. The sequential appearance of Ia-like antigens and two different complement receptors during the maturation of human neutrophils.
Aune et al. Activation of a suppressor T-cell pathway by interferon.
Bogen et al. Association of murine CD31 with transmigrating lymphocytes following antigenic stimulation
Preud'Homme et al. Idiotype‐bearing and antigen‐binding receptors produced by blood T lymphocytes in a case of human myeloma
Hersey et al. Antibody-dependent, cell-mediated cytotoxicity against melanoma cells induced by plasmapheresis
Ran et al. Tumor‐associated immunogolobulins. The elution of IgG2 from mouse tumors
KR900005998A (ko) 한외여과에 의한 단백질의 강화 및 농축방법
IL126366A0 (en) Photopheresis treatment of leukocytes
Hansson et al. Fc-mediated binding of IgG to vimentin-type intermediate filaments in vascular endothelial cells.
EP0674661A4 (en) TITRATION AND TREATMENT FOR DEMYELINIZING DISEASES SUCH AS MULTIPLE SCLEROSIS.
GB2188941B (en) Monoclonal antibodies recognizing human interleukin-2-receptor
Maino et al. Mechanism of Thy-1-mediated T cell activation: roles of Fc receptors, T200, Ia, and H-2 glycoproteins in accessory cell function.
Okamura et al. Antigen depressant effect of glutaraldehyde for aortic heterografts with a valve, with special reference to a concentration right fit for the preservation of grafts
FR2442909A1 (fr) Fibres cellulosiques ayant une affinite a la teinture amelioree, leur procede de preparation et procede d'impression par rongeage
ATE51864T1 (de) Alicyclische substituierte oxazolidin-2,4-dione mit hypoglykaemischer wirkung.
Andersson et al. Molecular identification of T cell‐specific antigens on human T lymphocytes and thymocytes
EP0845540A4 (en) MONOCLONAL ANTIBODIES AND ANTIGENS RELATED TO HUMAN LUNG ADENOCARCINOMA AND IMMUNOASSAY METHOD USING THE SAME
FR2435040A1 (fr) Composition pour determiner l'immunoglobuline g humaine, procede pour sa preparation et son emploi
Reyes et al. Human normoblast A antigen seen by immunoelectron microscopy
Tarkkanen et al. Suppressor cells of natural killer activity in normal and tumor-bearing individuals
Daniels,* et al. A monoclonal antibody related to the human blood group Gerbich
DE69011898D1 (de) Gegen menschlichen Papillomavirus monoklonaler Antikörper, Hybridom, das ihn produziert, und Verfahren zur Herstellung.

Legal Events

Date Code Title Description
ST Notification of lapse